Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.

Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.

Bibliografiset tiedot
Päätekijät:	Chakraverty, R, Robinson, S, Peggs, K, Kottaridis, P, Watts, M, Ings, S, Hale, G, Waldmann, H, Linch, D, Goldstone, A, Mackinnon, S
Aineistotyyppi:	Journal article
Julkaistu:	2000

Samankaltaisia teoksia

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.
Tekijä: Chakraverty, R, et al.
Julkaistu: (2001)

Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
Tekijä: Mackinnon, S, et al.
Julkaistu: (1999)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Tekijä: Hale, G, et al.
Julkaistu: (1988)

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions.
Tekijä: D'Sa, S, et al.
Julkaistu: (2003)

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
Tekijä: Chakraverty, R, et al.
Julkaistu: (2002)

Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
Tekijä: Hale, G, et al.
Julkaistu: (1997)

Outcome following T-cell depletion of allogeneic peripheral blood progenitor cells for transplantation
Tekijä: Novitzky, N, et al.
Julkaistu: (1997)

An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion.
Tekijä: Kottaridis, P, et al.
Julkaistu: (1999)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
Tekijä: Davison, G, et al.
Julkaistu: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
Tekijä: Davison, G, et al.
Julkaistu: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
Tekijä: Davison, G, et al.
Julkaistu: (1998)

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
Tekijä: Peggs, K, et al.
Julkaistu: (2003)

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Tekijä: Kottaridis, P, et al.
Julkaistu: (2000)

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.
Tekijä: Mead, A, et al.
Julkaistu: (2010)

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
Tekijä: Kottaridis, P, et al.
Julkaistu: (2001)

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Tekijä: Chakrabarti, S, et al.
Julkaistu: (2002)

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.
Tekijä: Peggs, K, et al.
Julkaistu: (2005)

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.
Tekijä: Craddock, C, et al.
Julkaistu: (2010)

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia
Tekijä: Charles Craddock, et al.
Julkaistu: (2010-06-01)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
Tekijä: Chakrabarti, S, et al.
Julkaistu: (2003)

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
Tekijä: Slavin, S, et al.
Julkaistu: (1985)

BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CML - THE ROLE OF T-CELL DEPLETION IN 1988
Tekijä: Mackinnon, S, et al.
Julkaistu: (1988)

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.
Tekijä: Chakrabarti, S, et al.
Julkaistu: (2002)

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
Tekijä: Manar S. Shafat, et al.
Julkaistu: (2020-07-01)

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function
Tekijä: Maria M. Cuadrado, et al.
Julkaistu: (2019-11-01)

Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
Tekijä: Barge, R, et al.
Julkaistu: (2001)

Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
Tekijä: Ferrara James L.M.
Julkaistu: (2002-01-01)

Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
Tekijä: Chakrabarti, S, et al.
Julkaistu: (2004)

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
Tekijä: Novitzky, N, et al.
Julkaistu: (2002)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
Tekijä: Hale, G, et al.
Julkaistu: (1998)

Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
Tekijä: Novitzky, N, et al.
Julkaistu: (2003)

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
Tekijä: Novitzky, N, et al.
Julkaistu: (2004)

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
Tekijä: Novitzky, N, et al.
Julkaistu: (2004)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
Tekijä: Heit, W, et al.
Julkaistu: (1986)

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust
Tekijä: Eliza Wiercinska, et al.
Julkaistu: (2021-08-01)

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
Tekijä: Yun Fan, et al.
Julkaistu: (2019-01-01)

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab.
Tekijä: Avivi, I, et al.
Julkaistu: (2004)

Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion.
Tekijä: Cullis, J, et al.
Julkaistu: (1993)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
Tekijä: Apperley, J, et al.
Julkaistu: (1985)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
Tekijä: Novitzky, N, et al.
Julkaistu: (2004)